{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:16:47Z","timestamp":1790299007925,"version":"4.1.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171507"],"award-info":[{"award-number":["82171507"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006739","name":"Capital Foundation of Medical Development","doi-asserted-by":"publisher","award":["2022-1-2131"],"award-info":[{"award-number":["2022-1-2131"]}],"id":[{"id":"10.13039\/501100006739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schizophr"],"DOI":"10.1038\/s41537-025-00576-3","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T01:04:57Z","timestamp":1740013497000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cardiovascular comorbidities in Chinese inpatients with schizophrenia spectrum disorders"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1642-2967","authenticated-orcid":false,"given":"Zhe","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baopeng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fude","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7979-1786","authenticated-orcid":false,"given":"Alice","family":"Kochunov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kochunov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengmei","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6011-5948","authenticated-orcid":false,"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Elliot","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3522-3912","authenticated-orcid":false,"given":"Yunlong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"key":"576_CR1","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/wps.20994","volume":"21","author":"CU Correll","year":"2022","unstructured":"Correll, C. U. et al. Mortality in people with schizophrenia: a systematic review and meta-analysis of relative risk and aggravating or attenuating factors. World Psychiatry 21, 248\u2013271 (2022).","journal-title":"World Psychiatry"},{"key":"576_CR2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/wps.20420","volume":"16","author":"CU Correll","year":"2017","unstructured":"Correll, C. U. et al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry 16, 163\u2013180 (2017).","journal-title":"World Psychiatry"},{"key":"576_CR3","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/S2215-0366(15)00115-7","volume":"2","author":"DC Henderson","year":"2015","unstructured":"Henderson, D. C., Vincenzi, B., Andrea, N. V., Ulloa, M. & Copeland, P. M. Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses. Lancet Psychiatry 2, 452\u2013464 (2015).","journal-title":"Lancet Psychiatry"},{"key":"576_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/YCO.0000000000000532","volume":"32","author":"I \u0160imunovi\u0107 Filip\u010di\u0107","year":"2019","unstructured":"\u0160imunovi\u0107 Filip\u010di\u0107, I., Baji\u0107, \u017d. & Filip\u010di\u0107, I. Effects of chronic physical illness on treatment outcomes among patients with schizophrenia. Curr. Opin. Psychiatry 32, 451\u2013460 (2019).","journal-title":"Curr. Opin. Psychiatry"},{"key":"576_CR5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1370\/afm.983","volume":"7","author":"JM Valderas","year":"2009","unstructured":"Valderas, J. M., Starfield, B., Sibbald, B., Salisbury, C. & Roland, M. Defining comorbidity: implications for understanding health and health services. Ann. Fam. Med. 7, 357\u2013363 (2009).","journal-title":"Ann. Fam. Med."},{"key":"576_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.genhosppsych.2020.06.010","volume":"66","author":"ML Goldman","year":"2020","unstructured":"Goldman, M. L. et al. Medical comorbid diagnoses among adult psychiatric inpatients. Gen. Hosp. Psychiatry 66, 16\u201323 (2020).","journal-title":"Gen. Hosp. Psychiatry"},{"key":"576_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.psychres.2013.05.013","volume":"210","author":"J Tsai","year":"2013","unstructured":"Tsai, J. & Rosenheck, R. A. Psychiatric comorbidity among adults with schizophrenia: a latent class analysis. Psychiatry Res. 210, 16\u201320 (2013).","journal-title":"Psychiatry Res."},{"key":"576_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2021.102927","volume":"67","author":"X Han","year":"2022","unstructured":"Han, X. et al. Comorbidity combinations in schizophrenia inpatients and their associations with service utilization: a medical record-based analysis using association rule mining. Asian J. Psychiatry 67, 102927 (2022).","journal-title":"Asian J. Psychiatry"},{"key":"576_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-01916-y","volume":"12","author":"C Lu","year":"2022","unstructured":"Lu, C. et al. Large-scale real-world data analysis identifies comorbidity patterns in schizophrenia. Transl. Psychiatry 12, 154 (2022).","journal-title":"Transl. Psychiatry"},{"key":"576_CR10","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.jad.2017.09.002","volume":"225","author":"L Ayerbe","year":"2018","unstructured":"Ayerbe, L. et al. Hypertension risk and clinical care in patients with bipolar disorder or schizophrenia; a systematic review and meta-analysis. J. Affect. Disord. 225, 665\u2013670 (2018).","journal-title":"J. Affect. Disord."},{"key":"576_CR11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1136\/postgradmedj-2021-141386","volume":"99","author":"Y Sudarshan","year":"2023","unstructured":"Sudarshan, Y. & Cheung, B. M. Y. Hypertension and psychosis. Postgrad. Med. J. 99, 411\u2013415 (2023).","journal-title":"Postgrad. Med. J."},{"key":"576_CR12","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1177\/0706743720904845","volume":"65","author":"TS Hauck","year":"2020","unstructured":"Hauck, T. S., Liu, N., Wijeysundera, H. C. & Kurdyak, P. Mortality and revascularization among myocardial infarction patients with schizophrenia: a Population-Based Cohort Study. Can. J. Psychiatry Rev. Can. Psychiatr. 65, 454\u2013462 (2020).","journal-title":"Can. J. Psychiatry Rev. Can. Psychiatr."},{"key":"576_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.schres.2023.04.006","volume":"257","author":"L Kruckow","year":"2023","unstructured":"Kruckow, L., Basit, S., Nordentoft, M., Banner, J. & Boyd, H. A. The influence of comorbid disease on premature death due to natural and unnatural causes in persons with schizophrenia. Schizophr. Res. 257, 27\u201333 (2023).","journal-title":"Schizophr. Res."},{"key":"576_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/acps.12265","volume":"130","author":"J Assies","year":"2014","unstructured":"Assies, J. et al. Effects of oxidative stress on fatty acid- and one-carbon-metabolism in psychiatric and cardiovascular disease comorbidity. Acta Psychiatr. Scand. 130, 163\u2013180 (2014).","journal-title":"Acta Psychiatr. Scand."},{"key":"576_CR15","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1093\/schbul\/sbw028","volume":"42","author":"I Dieset","year":"2016","unstructured":"Dieset, I., Andreassen, O. A. & Haukvik, U. K. Somatic comorbidity in schizophrenia: some possible biological mechanisms across the life span. Schizophr. Bull. 42, 1316\u20131319 (2016).","journal-title":"Schizophr. Bull."},{"key":"576_CR16","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1176\/appi.ajp.20220660","volume":"180","author":"L R\u00f8devand","year":"2023","unstructured":"R\u00f8devand, L. et al. Characterizing the shared genetic underpinnings of schizophrenia and cardiovascular disease risk factors. Am. J. Psychiatry 180, 815\u2013826 (2023).","journal-title":"Am. J. Psychiatry"},{"key":"576_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2021.114233","volume":"306","author":"M Castillo-S\u00e1nchez","year":"2021","unstructured":"Castillo-S\u00e1nchez, M. et al. Cardiovascular disease and mortality in people with schizophrenia or antipsychotic treatment: a cohort study in primary care. Psychiatry Res. 306, 114233 (2021).","journal-title":"Psychiatry Res."},{"key":"576_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1192\/bjp.bp.106.031716","volume":"191","author":"P Mackin","year":"2007","unstructured":"Mackin, P., Bishop, D., Watkinson, H., Gallagher, P. & Ferrier, I. N. Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community. Br. J. Psychiatry: J. Ment. Sci. 191, 23\u201329 (2007).","journal-title":"Br. J. Psychiatry: J. Ment. Sci."},{"key":"576_CR19","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nrendo.2011.156","volume":"8","author":"M De Hert","year":"2011","unstructured":"De Hert, M., Detraux, J., van Winkel, R., Yu, W. & Correll, C. U. Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat. Rev. Endocrinol. 8, 114\u2013126 (2011).","journal-title":"Nat. Rev. Endocrinol."},{"key":"576_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2020.102161","volume":"52","author":"J Chang","year":"2020","unstructured":"Chang, J. et al. Association of antipsychotics adherence and cardiovascular disease among newly diagnosed schizophrenia patients: a national cohort among Koreans. Asian J. Psychiatry 52, 102161 (2020).","journal-title":"Asian J. Psychiatry"},{"key":"576_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/wps.20252","volume":"14","author":"D Vancampfort","year":"2015","unstructured":"Vancampfort, D. et al. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry 14, 339\u2013347 (2015).","journal-title":"World Psychiatry"},{"key":"576_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-0722-0","volume":"10","author":"P Lacaze","year":"2020","unstructured":"Lacaze, P. et al. Genetic associations with clozapine-induced myocarditis in patients with schizophrenia. Transl. Psychiatry 10, 37 (2020).","journal-title":"Transl. Psychiatry"},{"key":"576_CR23","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jphs.2016.05.012","volume":"131","author":"Y Shinoda","year":"2016","unstructured":"Shinoda, Y. et al. Haloperidol aggravates transverse aortic constriction-induced heart failure via mitochondrial dysfunction. J. Pharmacol. Sci. 131, 172\u2013183 (2016).","journal-title":"J. Pharmacol. Sci."},{"key":"576_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0020-0190(89)90102-6","volume":"31","author":"T Kamada","year":"1989","unstructured":"Kamada, T. & Kawai, S. An algorithm for drawing general undirected graphs. Inf. Process. Lett. 31, 7\u201315 (1989).","journal-title":"Inf. Process. Lett."},{"key":"576_CR25","doi-asserted-by":"crossref","unstructured":"LCollins, L. M. & Lanza, S. T. Latent class and latent transition analysis: With applications in the social, behavioral, and health sciences. John Wiley & Sons. 718 (2009).","DOI":"10.1002\/9780470567333"},{"key":"576_CR26","doi-asserted-by":"crossref","unstructured":"Linzer, D. A. & Lewis, J. B. poLCA: An R package for polytomous variable latent class analysis. J Stat. Softw. 42, 1\u201329 (2011).","DOI":"10.18637\/jss.v042.i10"},{"key":"576_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-023-04424-w","volume":"23","author":"X Dai","year":"2023","unstructured":"Dai, X. et al. Analysis of inpatient cost burden and influencing factors of seniors\u2019 patients with mental illness in Dalian, China. BMC Geriatr. 23, 739 (2023).","journal-title":"BMC Geriatr."},{"key":"576_CR28","doi-asserted-by":"publisher","first-page":"e0256221","DOI":"10.1371\/journal.pone.0256221","volume":"16","author":"YS Jung","year":"2021","unstructured":"Jung, Y. S., Kim, Y. E., Go, D. S. & Yoon, S. J. The prevalence, incidence, and admission rate of diagnosed schizophrenia spectrum disorders in Korea, 2008\u20132017: a nationwide population-based study using claims big data analysis. PLoS ONE 16, e0256221 (2021).","journal-title":"PLoS ONE"},{"key":"576_CR29","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.schres.2016.06.023","volume":"176","author":"JOG K\u00fchl","year":"2016","unstructured":"K\u00fchl, J. O. G., Laursen, T. M., Thorup, A. & Nordentoft, M. The incidence of schizophrenia and schizophrenia spectrum disorders in Denmark in the period 2000\u20132012. A register-based study. Schizophr. Res. 176, 533\u2013539 (2016).","journal-title":"Schizophr. Res."},{"key":"576_CR30","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/acps.13565","volume":"148","author":"O K\u00f6hler-Forsberg","year":"2023","unstructured":"K\u00f6hler-Forsberg, O. et al. Schizophrenia spectrum disorders in Denmark between 2000 and 2018: incidence and early diagnostic transition. Acta Psychiatr. Scand. 148, 190\u2013198 (2023).","journal-title":"Acta Psychiatr. Scand."},{"key":"576_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.genhosppsych.2016.09.005","volume":"43","author":"G Rekhi","year":"2016","unstructured":"Rekhi, G., Khyne, T. T. & Lee, J. Estimating 10-year cardiovascular disease risk in Asian patients with schizophrenia. Gen. Hosp. Psychiatry 43, 46\u201350 (2016).","journal-title":"Gen. Hosp. Psychiatry"},{"key":"576_CR32","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1176\/appi.ajp.2021.21010031","volume":"178","author":"M Solmi","year":"2021","unstructured":"Solmi, M. et al. Disparities in screening and treatment of cardiovascular diseases in patients with mental disorders across the world: systematic review and meta-analysis of 47 observational studies. Am. J. Psychiatry 178, 793\u2013803 (2021).","journal-title":"Am. J. Psychiatry"},{"key":"576_CR33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.encep.2021.02.008","volume":"48","author":"JC Marche","year":"2022","unstructured":"Marche, J. C. et al. Prevalence of severe cardiovascular disease in patients with schizophrenia. L'Enc\u00e9phale 48, 125\u2013131 (2022).","journal-title":"L'Enc\u00e9phale"},{"key":"576_CR34","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/schbul\/sbr148","volume":"39","author":"AJ Mitchell","year":"2013","unstructured":"Mitchell, A. J. et al. Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders\u2013a systematic review and meta-analysis. Schizophr. Bull. 39, 306\u2013318 (2013).","journal-title":"Schizophr. Bull."},{"key":"576_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2023.111436","volume":"172","author":"EK Lamad\u00e9","year":"2023","unstructured":"Lamad\u00e9, E. K. et al. Association of hypertension, type 2 diabetes mellitus and dyslipidemia with the duration of inpatient treatments and recurrence of schizophrenia. J. Psychosom. Res. 172, 111436 (2023).","journal-title":"J. Psychosom. Res."},{"key":"576_CR36","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/da.23136","volume":"38","author":"T Kaiser","year":"2021","unstructured":"Kaiser, T., Herzog, P., Voderholzer, U. & Brakemeier, E. L. Unraveling the comorbidity of depression and anxiety in a large inpatient sample: Network analysis to examine bridge symptoms. Depress. Anxiety 38, 307\u2013317 (2021).","journal-title":"Depress. Anxiety"},{"key":"576_CR37","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/ehjqcco\/qcy055","volume":"5","author":"R Attar","year":"2019","unstructured":"Attar, R. et al. The effect of schizophrenia on major adverse cardiac events, length of hospital stay, and prevalence of somatic comorbidities following acute coronary syndrome. Eur. Heart J. Qual. Care Clin. Outcomes 5, 121\u2013126 (2019).","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"key":"576_CR38","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.jpsychires.2013.07.011","volume":"47","author":"Z Fan","year":"2013","unstructured":"Fan, Z., Wu, Y., Shen, J., Ji, T. & Zhan, R. Schizophrenia and the risk of cardiovascular diseases: a meta-analysis of thirteen cohort studies. J. Psychiatr. Res. 47, 1549\u20131556 (2013).","journal-title":"J. Psychiatr. Res."},{"key":"576_CR39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.eurpsy.2011.02.009","volume":"27","author":"D Schoepf","year":"2012","unstructured":"Schoepf, D. et al. Type-2 diabetes mellitus in schizophrenia: increased prevalence and major risk factor of excess mortality in a naturalistic 7-year follow-up. Eur. Psychiatry: J. Assoc. Eur. Psychiatr. 27, 33\u201342 (2012).","journal-title":"Eur. Psychiatry: J. Assoc. Eur. Psychiatr."},{"key":"576_CR40","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1017\/S2045796017000166","volume":"27","author":"J Westman","year":"2018","unstructured":"Westman, J. et al. Increased cardiovascular mortality in people with schizophrenia: a 24-year national register study. Epidemiol. Psychiatr. Sci. 27, 519\u2013527 (2018).","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"576_CR41","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/schbul\/sbab132","volume":"48","author":"RR Veeneman","year":"2022","unstructured":"Veeneman, R. R. et al. Exploring the relationship between schizophrenia and cardiovascular disease: a genetic correlation and multivariable Mendelian Randomization Study. Schizophr. Bull. 48, 463\u2013473 (2022).","journal-title":"Schizophr. Bull."},{"key":"576_CR42","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neubiorev.2017.10.020","volume":"84","author":"A Gadelha","year":"2018","unstructured":"Gadelha, A. et al. Is adenosine associated with sudden death in schizophrenia? A new framework linking the adenosine pathway to risk of sudden death. Neurosci. Biobehav. Rev. 84, 29\u201334 (2018).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"576_CR43","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.amjcard.2017.06.027","volume":"120","author":"M J\u00f8rgensen","year":"2017","unstructured":"J\u00f8rgensen, M., Mainz, J., Egstrup, K. & Johnsen, S. P. Quality of care and outcomes of heart failure among patients with schizophrenia in Denmark. Am. J. Cardiol. 120, 980\u2013985 (2017).","journal-title":"Am. J. Cardiol."},{"key":"576_CR44","doi-asserted-by":"publisher","first-page":"e2110096","DOI":"10.1001\/jamanetworkopen.2021.10096","volume":"4","author":"M Fenger-Gr\u00f8n","year":"2021","unstructured":"Fenger-Gr\u00f8n, M. et al. Association between bipolar disorder or schizophrenia and oral anticoagulation use in Danish adults with incident or prevalent atrial fibrillation. JAMA Netw. Open 4, e2110096 (2021).","journal-title":"JAMA Netw. Open"},{"key":"576_CR45","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1192\/bjp.2019.250","volume":"217","author":"CA Jackson","year":"2020","unstructured":"Jackson, C. A. et al. Incidence of ischaemic heart disease and stroke among people with psychiatric disorders: retrospective cohort study. Br. J. Psychiatry: J. Ment. Sci. 217, 442\u2013449, https:\/\/doi.org\/10.1192\/bjp.2019.250 (2020).","journal-title":"Br. J. Psychiatry: J. Ment. Sci."},{"key":"576_CR46","doi-asserted-by":"publisher","first-page":"e1003960","DOI":"10.1371\/journal.pmed.1003960","volume":"19","author":"AM Lambert","year":"2022","unstructured":"Lambert, A. M. et al. Temporal trends in associations between severe mental illness and risk of cardiovascular disease: a systematic review and meta-analysis. PLoS Med. 19, e1003960 (2022).","journal-title":"PLoS Med."},{"key":"576_CR47","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.schres.2019.07.058","volume":"212","author":"I Krieger","year":"2019","unstructured":"Krieger, I., Tzur Bitan, D., Comaneshter, D., Cohen, A. & Feingold, D. Increased risk of smoking-related illnesses in schizophrenia patients: a nationwide cohort study. Schizophr. Res. 212, 121\u2013125 (2019).","journal-title":"Schizophr. Res."},{"key":"576_CR48","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1001\/jamapsychiatry.2023.0171","volume":"80","author":"SK Wagner","year":"2023","unstructured":"Wagner, S. K. et al. Association between retinal features from multimodal imaging and schizophrenia. JAMA Psychiatry 80, 478\u2013487 (2023).","journal-title":"JAMA Psychiatry"},{"key":"576_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2022.103042","volume":"70","author":"V Korann","year":"2022","unstructured":"Korann, V. et al. Association between retinal vascular measures and brain white matter lesions in schizophrenia. Asian J. Psychiatry 70, 103042 (2022).","journal-title":"Asian J. Psychiatry"},{"key":"576_CR50","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.pnpbp.2018.05.005","volume":"86","author":"B Misiak","year":"2018","unstructured":"Misiak, B., Stramecki, F., Sta\u0144czykiewicz, B., Frydecka, D. & Lubeiro, A. Vascular endothelial growth factor in patients with schizophrenia: a systematic review and meta-analysis. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 86, 24\u201329 (2018).","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"576_CR51","first-page":"620","volume":"43","author":"J Hua","year":"2017","unstructured":"Hua, J. et al. Abnormal grey matter arteriolar cerebral blood volume in schizophrenia measured with 3D inflow-based vascular-space-occupancy MRI at 7T. Schizophr. Bull. 43, 620\u2013632 (2017).","journal-title":"Schizophr. Bull."},{"key":"576_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.103","volume":"5","author":"HW Moises","year":"2015","unstructured":"Moises, H. W., Wollschl\u00e4ger, D. & Binder, H. Functional genomics indicate that schizophrenia may be an adult vascular-ischemic disorder. Transl. Psychiatry 5, e616 (2015).","journal-title":"Transl. Psychiatry"},{"key":"576_CR53","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/jech-2017-209565","volume":"72","author":"M Chiu","year":"2018","unstructured":"Chiu, M., Rahman, F., Vigod, S., Wilton, A. S. & Kurdyak, P. Temporal trends in cardiovascular disease risk factor profiles in a population-based schizophrenia sample: a repeat cross-sectional study. J. Epidemiol. Community Health 72, 71\u201377 (2018).","journal-title":"J. Epidemiol. Community Health"},{"key":"576_CR54","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/sms.13371","volume":"29","author":"MF Brobakken","year":"2019","unstructured":"Brobakken, M. F. et al. A comprehensive cardiovascular disease risk profile in patients with schizophrenia. Scand. J. Med. Sci. Sports 29, 575\u2013585 (2019).","journal-title":"Scand. J. Med. Sci. Sports"},{"key":"576_CR55","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.psychres.2018.04.020","volume":"264","author":"S Zhao","year":"2018","unstructured":"Zhao, S. et al. 10-year CVD risk in Han Chinese mainland patients with schizophrenia. Psychiatry Res. 264, 322\u2013326 (2018).","journal-title":"Psychiatry Res."},{"key":"576_CR56","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.032625","volume":"13","author":"J Komuro","year":"2024","unstructured":"Komuro, J. et al. Sex differences in the relationship between schizophrenia and the development of cardiovascular disease. J. Am. Heart Assoc. 13, e032625 (2024).","journal-title":"J. Am. Heart Assoc."},{"key":"576_CR57","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1093\/eurheartj\/ehx159","volume":"38","author":"I Kosmidou","year":"2017","unstructured":"Kosmidou, I. et al. Infarct size, left ventricular function, and prognosis in women compared to men after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: results from an individual patient-level pooled analysis of 10 randomized trials. Eur. Heart J. 38, 1656\u20131663 (2017).","journal-title":"Eur. Heart J."},{"key":"576_CR58","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1177\/0706743720948429","volume":"66","author":"PH Chen","year":"2021","unstructured":"Chen, P. H. et al. Age Effect on Incidence, Physical, and Psychiatric Comorbidity for Sudden Cardiac Death in Schizophrenia: Effet de l'\u00e2ge sur l\u2019incidence, la comorbidit\u00e9 physique et psychiatrique de la mort cardiaque subite dans la schizophr\u00e9nie. Can. J. Psychiatry Rev. Can. Psychiatr. 66, 367\u2013375 (2021).","journal-title":"Can. J. Psychiatry Rev. Can. Psychiatr."},{"key":"576_CR59","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.comppsych.2013.09.009","volume":"55","author":"H Carliner","year":"2014","unstructured":"Carliner, H. et al. Prevalence of cardiovascular risk factors among racial and ethnic minorities with schizophrenia spectrum and bipolar disorders: a critical literature review. Compr. Psychiatry 55, 233\u2013247 (2014).","journal-title":"Compr. Psychiatry"},{"key":"576_CR60","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1378\/chest.72.5.623","volume":"72","author":"U Elkayam","year":"1977","unstructured":"Elkayam, U., Rotmensch, H. H., Terdiman, R., Geller, E. & Laniado, S. Hemodynamic effects of chlorpromazine in patients with acute myocardial infarction and pump failure. Chest 72, 623\u2013627 (1977).","journal-title":"Chest"},{"key":"576_CR61","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/JCP.0b013e318283983f","volume":"33","author":"S Gopal","year":"2013","unstructured":"Gopal, S. et al. Risk of cardiovascular morbidity with risperidone or paliperidone treatment: analysis of 64 randomized, double-blind trials. J. Clin. Psychopharmacol. 33, 157\u2013161 (2013).","journal-title":"J. Clin. Psychopharmacol."},{"key":"576_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2023.115336","volume":"326","author":"E Clapham","year":"2023","unstructured":"Clapham, E. et al. The association between exposure to clozapine, olanzapine, and quetiapine and the outcomes perimyocarditis and heart failure: a population-based cohort study. Psychiatry Res. 326, 115336 (2023).","journal-title":"Psychiatry Res."},{"key":"576_CR63","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ajem.2020.04.013","volume":"44","author":"J Lin","year":"2021","unstructured":"Lin, J. et al. Efficacy of ketamine for initial control of acute agitation in the emergency department: a randomized study. Am. J. Emerg. Med. 44, 306\u2013311 (2021).","journal-title":"Am. J. Emerg. Med."},{"key":"576_CR64","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/JCP.0000000000001362","volume":"41","author":"A Costa","year":"2021","unstructured":"Costa, A. et al. Effects of oral administration of alprazolam and lorazepam as hypnotics on cardiovascular parameters in hypertensive patients. J. Clin. Psychopharmacol. 41, 191\u2013195 (2021).","journal-title":"J. Clin. Psychopharmacol."},{"key":"576_CR65","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1055\/s-0038-1639501","volume":"44","author":"S Hoirisch-Clapauch","year":"2018","unstructured":"Hoirisch-Clapauch, S. Anxiety-related bleeding and thrombosis. Semin. Thromb. Hemost. 44, 656\u2013661 (2018).","journal-title":"Semin. Thromb. Hemost."},{"key":"576_CR66","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1159\/000287624","volume":"38","author":"R Fontaine","year":"1982","unstructured":"Fontaine, R. & Boisvert, D. Psychophysiological disorders in anxious patients: hypertension and hypotension. Psychother. Psychosom. 38, 165\u2013172 (1982).","journal-title":"Psychother. Psychosom."},{"key":"576_CR67","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00414-010-0449-1","volume":"124","author":"AL Pelissier-Alicot","year":"2010","unstructured":"Pelissier-Alicot, A. L. et al. Buprenorphine-related deaths: unusual forensic situations. Int. J. Leg. Med. 124, 647\u2013651 (2010).","journal-title":"Int. J. Leg. Med."},{"key":"576_CR68","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1002\/ejhf.2602","volume":"24","author":"A Dom\u00ednguez-Rodr\u00edguez","year":"2022","unstructured":"Dom\u00ednguez-Rodr\u00edguez, A. et al. Midazolam versus morphine in acute cardiogenic pulmonary oedema: results of a multicentre, open-label, randomized controlled trial. Eur. J. Heart Fail. 24, 1953\u20131962 (2022).","journal-title":"Eur. J. Heart Fail."},{"key":"576_CR69","first-page":"428","volume":"41","author":"MF Peixoto","year":"2019","unstructured":"Peixoto, M. F., Cesaretti, M., Hood, S. D. & Tavares, A. Effects of SSRI medication on heart rate and blood pressure in individuals with hypertension and depression. Clin. Exp. Hypertens. (New York, NY: 1993) 41, 428\u2013433 (2019).","journal-title":"Clin. Exp. Hypertens. (New York, NY: 1993)"},{"key":"576_CR70","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1001\/jama.2016.7635","volume":"315","author":"CE Angermann","year":"2016","unstructured":"Angermann, C. E. et al. Effect of escitalopram on all-cause mortality and hospitalization in patients with heart failure and depression: the MOOD-HF Randomized Clinical Trial. JAMA 315, 2683\u20132693 (2016).","journal-title":"JAMA"},{"key":"576_CR71","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/00048670802534341","volume":"43","author":"JL Elmslie","year":"2009","unstructured":"Elmslie, J. L. et al. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls. Aust. N. Z. J. Psychiatry 43, 53\u201360 (2009).","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"576_CR72","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1161\/CIRCRESAHA.113.301071","volume":"112","author":"HA Lee","year":"2013","unstructured":"Lee, H. A. et al. Histone deacetylase inhibition attenuates transcriptional activity of mineralocorticoid receptor through its acetylation and prevents development of hypertension. Circ. Res. 112, 1004\u20131012 (2013).","journal-title":"Circ. Res."},{"key":"576_CR73","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1124\/mol.114.096974","volume":"87","author":"SH Kang","year":"2015","unstructured":"Kang, S. H. et al. Histone deacetylase inhibition attenuates cardiac hypertrophy and fibrosis through acetylation of mineralocorticoid receptor in spontaneously hypertensive rats. Mol. Pharmacol. 87, 782\u2013791 (2015).","journal-title":"Mol. Pharmacol."}],"container-title":["Schizophrenia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41537-025-00576-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41537-025-00576-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41537-025-00576-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T01:07:00Z","timestamp":1740013620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41537-025-00576-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["576"],"URL":"https:\/\/doi.org\/10.1038\/s41537-025-00576-3","relation":{},"ISSN":["2754-6993"],"issn-type":[{"value":"2754-6993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"assertion":[{"value":"21 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of the Ethics Committee of Peking University Huilongguan School of Clinical Medicine [(2023) Research No. 104].","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}